Skip to content
Open access

Gene-virus interaction between IFN-γ rs2069705 polymorphism and Epstein-Barr virus in breast cancer susceptibility among Egyptian women.

Aug 2026 · Biomarkers in Medicine · Vol 20, pp. 1-11 · 0 citations · 28 references
Medicine

TL;DR

EBV infection and IFN-γ rs2069705 polymorphism may contribute to BC susceptibility and progression among Egyptian women and could serve as potential combined biomarkers for risk assessment and prognosis.

Abstract

Aims

This study investigated the association between Epstein-Barr virus (EBV) infection and breast cancer (BC) susceptibility and evaluated the role of interferon-gamma (IFN-γ) rs2069705 polymorphism in disease risk and clinicopathological characteristics among Egyptian women.

Materials And Methods

A case-control study was conducted on 96 histologically confirmed BC patients and 50 age-matched healthy controls. EBV serostatus was assessed by ELISA detection of anti-viral capsid antigen IgG antibodies. IFN-γ rs2069705 (A/G) genotyping was performed using TaqMan real-time PCR assays.

Results

EBV seropositivity was significantly higher in BC patients (93.75%) than controls (p = 0.008). Significant associations were observed between IFN-γ rs2069705 polymorphism and BC susceptibility, particularly for AA and AG genotypes and A and G alleles (p < 0.001), whereas the GG genotype showed no significant association. AA and AG genotypes were also associated with unfavorable clinicopathological features.

Conclusion

EBV infection and IFN-γ rs2069705 polymorphism may contribute to BC susceptibility and progression among Egyptian women and could serve as potential combined biomarkers for risk assessment and prognosis.

Read PDF

Similar papers

Aug 2026

Genetic variation in IL-6 rs1800796 and its association with non-Hodgkin lymphoma susceptibility in the Egyptian population

The results support the use of the IL-6 variation in the diagnosis and genetic screening of NHL but not for therapeutic choices, and suggest that individuals carrying the G allele may be at twice the risk of developing NHL compared with those carrying the C allele.

Heba Shamshoun, Mai M. Madkour, A. Elsaid et al. · 0 citations
Open access Sep 2026

Distribution of HLA-G Alleles and Oncogenic Viruses in Laryngeal Squamous Cell Carcinoma

HLA-G polymorphisms and various oncogenic viruses have been demonstrated in cancers of different anatomical sites. The study aimed to investigate the distribution and potential association of HLA-G alleles and the presence of human papillomavirus (HPV), Epstein–Barr virus (EBV), BK polyomavirus (BKPyV), and JC polyomav...

L. Božić, A. Šmitran, M. Travar et al. · 0 citations
Open access Sep 2026

Association of MDM2 rs2279744 and rs937282 polymorphisms with breast cancer susceptibility and circulating MDM2 and p53 levels in Bangladeshi women: A case-control study

Background The MDM2–p53 signaling pathway plays a central role in tumor suppression, and genetic variants that disrupt this pathway may influence breast cancer (BC) susceptibility. However, data from South Asian populations, particularly Bangladesh, remain limited. Methods A case–control study was conducted in Banglade...

M. H. Chowdhury, Farzana Islam, A. Khan et al. · 0 citations
Open access Aug 2026

Association of HLA-G alleles with type-specific HPV seropositivity and seropersistence in unvaccinated women: A prospective cohort study.

INTRODUCTION The human leukocyte antigen G (HLA-G) allele repertoire is crucial for cell-mediated immune responses. While HLA-G's role in human papillomavirus (HPV) infection is increasingly studied, research on HLA-G and humoral immunity remains limited. This study aimed to establish whether HLA-G alleles impact type-...

Kalle Anttonen, Nelli Kalliomaa, M. Roger et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.